The average stock in the Dow Jones Industrial Average is down 16.24% on a total return basis so far in 2020.  Below we take a look at how the “Dogs of the Dow” strategy has performed so far this year.

The “Dogs of the Dow” strategy is a very passive approach that simply says to buy the 10 stocks in the Dow 30 that have the highest dividend yields at the start of each year.  The Dogs list for 2020 was led by Dow Inc. (DOW) with a yield of 5.12% on January 1st.  Exxon Mobil (XOM), IBM, Verizon (VZ), Chevron (CVX), Pfizer (PFE), 3M (MMM), Walgreens (WBA), Cisco (CSCO), and Coca-Cola (KO) are the nine other members of the Dogs for 2020.

As shown in the table below, the Dogs are down an average of 19.37% on a total return basis in 2020, which is a little less than five percentage points worse than the 14.68% decline seen for the 20 non-Dogs this year.  Dow Inc. (DOW) and Exxon Mobil (XOM) have been the two worst performing Dogs with respective YTD declines of 39.9% and 37.0%.  Dow’s dividend yield has risen from 5.12% up to 8.47%, while XOM’s yield has risen from 4.99% up to 7.91%.  There are no Dogs that are up on the year, but Verizon (VZ) and Pfizer (PFE) have been the best performers of the group with YTD declines of less than 5%.

Of the non-Dogs, Boeing (BA) has been by far the worst performer with a YTD decline of 60.01%.  At the start of 2020, BA had a dividend yield of 2.52%, but that dividend has been suspended.  JP Morgan (JPM), American Express (AXP) and Disney (DIS) have all fallen more than 30% YTD, while Johnson & Johnson (JNJ), Walmart (WMT), and Microsoft (MSFT) are the only three Dow stocks that are up on the year.  Read our weekly Bespoke Report newsletter released every Friday with a two-week free trial to Bespoke Premium.

We’re now two weeks into the Q1 2020 earnings season, and just over 200 companies have reported their numbers so far.  The average one-day price change for the stocks that have reported earnings so far this season has been a gain of 0.89%.  That’s much stronger than the average one-day gain of 0.06% seen for all stocks that have reported earnings since 2001.

As shown below, stocks that have beaten EPS estimates this season have averaged a one-day price gain of 2.16% on their earnings reaction days.  That’s stronger than the average one-day gain of 1.89% seen on earnings reaction days for all stocks that have reported since 2001.  Stocks that have missed EPS estimates this season have seen a one-day decline of 0.72% on their earnings reaction days.  Historically, the average stock that has missed EPS has fallen 3.56% on its earnings reaction day, so this season’s decline of just 0.72% suggests that investors are basically giving a pass to companies missing estimates in Q1.  Read our weekly Bespoke Report newsletter published every Friday with a two-week free trial to Bespoke Premium.

Even though most economic data releases this week that had forecasts exceeded those estimates (10 of 15), data continues to come in very weak. The Chicago Fed’s National Activity index started off the week coming in at –4.19 which was well below estimates of –3. Existing home sales followed up on Tuesday, and despite coming in above estimates, sales slowed considerably from February. Elsewhere in housing data, new home sales collapsed down to 627K SAAR compared to 765K last month. Meanwhile, February home prices showed some acceleration. Jobless claims also were better than expected, but they too remain at extremely elevated levels relative to the rest of history. Manufacturing data was a major area of weakness this week. Both the preliminary Markit PMI and Kansas City Fed reading fell significantly despite coming in better than forecast. Hard manufacturing data on Friday was likewise bad at the headline level though under the hood there were some silver linings.

Turning to next week, like the earnings calendar, the economic calendar ramps up with a total of 34 releases. We will get the final two regional Federal Reserve indices from Dallas and Richmond on Monday and Tuesday, respectively, followed by the final Markit and ISM reading for April on Friday. Wednesday will be the most closely watched day of the week with the first release of Q1 GDP as well as an FOMC rate decision. Growth in the first quarter is expected to show a 3.8% contraction. Although no change in rates is being forecast, Fed Chair Powell’s following presser will likely be closely watched for a monetary policy update. Start a two-week free trial to Bespoke Institutional to access our interactive economic indicators monitor and much more.

The earnings calendar has begun to ramp up over the past two weeks and over the next two weeks we will see peak earnings season.  Next week there are a total of 784 companies scheduled to release earnings.  Of those, there are 178 S&P 500 stocks, which is 35.% of the index.

In the table below we show the 30 largest stocks (by market cap) that are scheduled to report next week. None of the largest stocks report on Monday, but the two Dow pharmaceutical stocks, Merck (MRK) and Pfizer (PFE), kick things off Tuesday morning. The trillion dollar market cap club will all report next week with Microsoft (MSFT) out with earnings Wednesday night and Apple (AAPL) and Amazon (AMZN) out the following evening. Two other notable releases Wednesday and Thursday, respectively, will be the major payment processors Visa (V) and Mastercard (MA).  Friday will be capped off with two oil giants: Exxon Mobil (XOM) and Chevron (CVX).  Other honorable mentions not on this list reporting next week include industrial bell-weather Caterpillar (CAT), stocks likely benefiting from the COVID economy like Colgate Palmolive (CL) and Clorox (CLX), and finally, some travel and leisure stocks like Expedia (EXPE), Royal Caribbean (RCL), United Airlines (UAL), and Southwest Airlines (LUV).  Keep track of all upcoming earnings with our Earnings Explorer.  Start a two-week free trial to Bespoke Premium to access Earnings Explorer tool and more.

Today’s preliminary report on manufacturers’ new orders, sales, and inventories was mixed, with a huge headline drop but stronger results under the hood…especially relative to disastrous manufacturing sentiment series in March and April. Leaving aside the broader implications of the report, we wanted to highlight one series in particular. With Boeing (BA) reeling from the ongoing problems with its 737-MAX design and the global shock to its customers in the form of COVID-19, the US aerospace industry is under immense pressure. Things are so bad that orders are being canceled faster than new orders are placed. That situation is not without precedent; it applied for a stretch in 2008-2009 as well. But the scale of net negative order growth is much, much larger this time around. Across all US manufacturers in March, $16.35bn more orders were canceled than new orders received.  Start a two-week free trial to Bespoke Institutional to access our Chart Scanner, custom screens, and much more.

With central banks around the world unleashing waves of liquidity, there have been heightened concerns that one result will be a decline in the purchasing power of our money.  For that reason, a number of investors have been flocking to gold. Even before the COVID-19 crisis, gold prices had been in a solid uptrend, and while prices spiked as the crisis first began, they couldn’t quite get above the $1,650 – $1,700 range.  In mid-March even, prices plummeted with just about every other financial asset before quickly recovering.  Once again, though, the rally stalled at resistance.  This time around, though, the 50-day moving average was strong enough to provide support and after that test, gold finally got the long-awaited breakout that investors had been waiting for.

Gold’s price spiked as high as $1,787 per ounce in mid-April before running out of momentum.  When a stock or commodity breaks out above resistance to new highs and then pulls back, the former resistance level should act as support, and that is exactly what we saw this time around.  This week, gold bounced right on cue at around $1,700 and has since rallied 2.6%.  With the first test of support proving successful, look for gold to now establish a new range with a floor at around $1,700.  At least that’s what the technical analysis textbooks would say.  Start a two-week free trial to Bespoke Institutional for access to our entire suite of market research and commentary.